Cargando…
Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
Non-small-cell lung cancer (NSCLC) is a dominating type of lung cancer with high morbidity and mortality. Midazolam has been reported to promote cell apoptosis in NSCLC, but the molecular mechanism of midazolam remains to be further explored. In the current work, cell viability, proliferation, migra...
Autores principales: | Zhang, Xiangchao, Han, Zhe, Li, Zhengjun, Wang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251164/ https://www.ncbi.nlm.nih.gov/pubmed/37305523 http://dx.doi.org/10.1515/med-2023-0730 |
Ejemplares similares
-
BCKDK Promotes Ovarian Cancer Proliferation and Migration by Activating the MEK/ERK Signaling Pathway
por: Li, Huashun, et al.
Publicado: (2022) -
PPP1R14D promotes the proliferation, migration and invasion of lung adenocarcinoma via the PKCα/BRAF/MEK/ERK signaling pathway
por: Cao, Huijun, et al.
Publicado: (2022) -
Zyxin Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma via Rap1-Mediated Inhibition of the MEK/ERK Signaling Pathway
por: Wei, Zhun, et al.
Publicado: (2023) -
KIF15 promotes bladder cancer proliferation via the MEK–ERK signaling pathway
por: Zhao, Hongda, et al.
Publicado: (2019) -
KIF15 promotes pancreatic cancer proliferation via the MEK–ERK signalling pathway
por: Wang, Jie, et al.
Publicado: (2017)